Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Chocolate PTA Balloon
Blackmores Limited
Atherosclerosis
1 trial -
Cisplatin Accord Healthcare 1 mg/ml concentraat voor oplossing voor infusie
Disc Medicine
Locally advanced head and neck squamous cell carcinoma
1 trial -
Citrate anticoagulation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
Coartem™ (Artemether-lumefantrine combination)
United Therapeutics Europe Ltd
Malaria
1 trial -
Cocaine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
4 trials -
Cocaine-Related Disorders
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
2 trials -
Colla corii asini
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thalassemia
1 trial -
Combination of antiplatelet drugs and anticoagulants for at least one month
The First People's Hospital of Lianyungang
Acute Myocardial Infarction
1 trial -
Conducted AF-Response Algorithm (CAFR) On
Rhythm Pharmaceuticals Netherlands B.V.
Heart Failure
1 trial -
Conivaptan
CUMBERLAND PHARMACEUTICALS INC
Hyponatremia
4 trials -
Conoxia® Vloeibaar, 100% v/v, medicinaal gas, cryogeen
Disc Medicine
Pulmonary Hypertension, Coronary Microvascular Dysfunction, Hypoxia, Heart Failure
1 trial -
Control: Femoral perineural local anesthetic infusion
Summit Therapeutics
Postoperative Pain Following Knee Arthroplasty
1 trial -
Copper IUD
United Therapeutics Europe Ltd
Mucosal Inflammation
1 trial -
D-CURE 25000 UI gélules., Placebo of vitamin D
Laboratoire HRA Pharma
Periodontitis
1 trial -
DABIGATRAN ETEXILATE , CLOPIDOGREL , RIVAROXABAN , APIXABAN , ACENOCOUMAROL , EDOXABAN
The George Institute
patients who are requested a colonoscopy for any indication and are under antiplatelet treatment (except ASA) or anticoagulant treatment
1 trial -
DARBEPOETIN ALFA
The George Institute
hepatic trasplant
1 trial -
DOAC
Rhythm Pharmaceuticals Netherlands B.V.
Ventricular Tachycardia
1 trial -
DOBUTAMINE , LEVOSIMENDAN
The George Institute
Heart failure patients with depressed left ventricular ejection fraction
1 trial -
DOTAREM 0,5 mmol/ml oplossing voor injectie in injectieflacons.
Disc Medicine
Breast Cancer
1 trial -
DUPILUMAB, Upadacitinib, Upadacitinib
AbbVie Deutschland GmbH & Co. KG
Atopic Dermatitis
1 trial -
Dabigatran Etexilate
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
De-escalated Dual Antiplatelet Therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
De-escalation strategy
Dong Wang
Acute Myocardial Infarction
1 trial -
Deltius 50.000 UI cápsulas duras. Colecalciferol (Vitamina D3), CALCIFEDIOL
Lacuna Pharma Pty Ltd
Severe vitamin D deficiency
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources